BioSpace News Archive

Anixa Biosciences, Inc., a biotechnology company focused on harnessing the body’s immune system in the fight against cancer, announced its collaboration with Urology San Antonio, PA in Anixa’s ongoing Cchek™ prostate cancer study.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the company was once again ranked as a top company to work for by Science magazine in its annual Top Employers Survey of the global biotech and pharmaceutical industry.

CAMP4 Therapeutics, a biotechnology company unraveling transcriptional machinery and the network of signaling pathways to accelerate drug discovery and development across therapeutic areas, announced that Richard Young, Ph.D., one of the company’s founders, has been elected to the National Academy of Medicine (NAM).

Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today provided updates on its lead development programs and business operations.

Data center infrastructure, specifically computing, memory, storage, and networking, is in the process of going through a reboot to support the growing artificial intelligence (AI) market, according to a new report from Tractica.

Microbion Corporation of Bozeman, MT, and Microbion Pharma Corp. of Vancouver, BC (“Microbion”) today announced that the World Health Organization (WHO) has recommended “pravibismane” as the International Nonproprietary Name (INN), also commonly known as a generic name, for Microbion’s lead broad-spectrum antimicrobial and antibiofilm agent.

Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it has entered into a $20.0 million common stock purchase agreement with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor.

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its fourth quarter fiscal 2019 conference call on Thursday, October 31, at 4 p.m. CT (5 p.m. ET)

Feinstein Institutes for Medical Research scientists published a review of a bioelectronic medicine strategy to treat hemorrhagic shock (HS) in the Springer Nature journal, Bioelectronic Medicine.

Nearly two years of real-world outcomes data on Abiomed’s Impella RP heart pump shows that when physicians followed the FDA’s approved protocol for Impella RP use they achieved 72% patient survival and 98% native heart recovery.